Skip to main content

Table 1 IC50 for cytotoxic activity of black ginseng extract in human cancer cell lines

From: Efficacy and safety evaluation of black ginseng (Panax ginseng C.A. Mey.) extract (CJ EnerG): broad spectrum cytotoxic activity in human cancer cell lines and 28-day repeated oral toxicity study in Sprague-Dawley rats

Test substance

IC50

A-431

A549

HT-29

NCI-N87

Capan-1

HepG2

BGE (μg/mL)

1302.1 ± 7.1

1461.4 ± 22.2**

1228.0 ± 19.9

1528.6 ± 55.2**

1453.4 ± 20.0**

1357.7 ± 30.3

RGE (μg/mL)

>  5000.0

>  5000.0

>  5000.0

>  5000.0

>  5000.0

>  5000.0

20(S)-Rg3 (μg/mL)

268.7 ± 7.4

262.9 ± 5.5

300.0 ± 5.0*

251.7 ± 1.0

269.2 ± 5.3

212.0 ± 20.3**

Rg5 (μg/mL)

39.2 ± 2.9

42.8 ± 8.5

50.0 ± 5.2

29.4 ± 0.6

41.6 ± 3.1

57.9 ± 2.6**

Paclitaxel (nM)

3.6 ± 0.3

4.0 ± 1.9

0.9 ± 0.3

118.8 ± 53.6**

21.5 ± 5.7

1.0 ± 0.1

  1. BGE Black ginseng extract, RGE Red ginseng extract; *; P < 0.05 and * P < 0.01 compared to IC50 of A-431 by one-way ANOVA followed by post-hoc Tukey HSD multiple comparison test